Lisa Tomlinson, Author at Rapid Dose Therapeutics

August 20, 2026
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip™ Nicotine Patent, Advancing RDT’s Global Commercialization Strategy

View News Release

July 28, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN® QuickStrip™ Curcumin Across Canada

View News Release

July 10, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

July 7, 2026
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization

View News Release

April 13, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets

View News Release

April 6, 2026
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

View News Release

March 26, 2026
Rapid Dose Therapeutics Reinforces Strategic Strength and Global Growth Trajectory

View News Release

March 5, 2026
Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF) Secures Patent for QuickStrip™ Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market

View News Release

February 23, 2026
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip™ Platform

View News Release

February 11, 2026
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors

View News Release

Latest News